Inhibition of Interleukin-33 to Reduce Glomerular Endothelial Inflammation in Diabetic Kidney Disease

Inhibition of Interleukin-33 to Reduce Glomerular Endothelial Inflammation in Diabetic Kidney Disease

Introduction: Inflammation is a significant contributor to cardiorenal morbidity and mortality in diabetic kidney disease (DKD). The pathophysiological mechanisms linking systemic, subacute inflammation and local, kidney injury-initiated immune maladaptation is partially understood. Methods: Here, w...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexis Hofherr, Elena Liarte Marin, Barbara Musial, Asha Seth, Tim Slidel, James Conway, David Baker, Pernille B.L. Hansen, Benjamin Challis, Stefano Bartesaghi, Maria Bhat, Roberto Pecoits-Filho, Xiao Tu, Viknesh Selvarajah, Kevin Woollard, Hiddo J.L. Heerspink
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Kidney International Reports
Subjects:
biomarker
diabetic kidney disease
IL-33
inflammation
phase 2b
tozorakimab
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924015791
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2468024924015791

Similar Items